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ABSTRACT
Background Hemodialysis treatment and the high 
stress brought about by the treatment are the circum-
stances which set the background for alexithymia. 
Alexithymic feelings basically emerge as restriction in 
the world of emotion and thought, and the inability to 
recognize physiological changes. Biomarkers that are 
indicators of physical change are influential in the stress 
lives of individuals. This research was carried out to 
discover the relationships between, and to determine the 
influence of urea, creatinine, sodium, potassium, hemo-
globin, hematocrit, albumin, calcium, phosphorus and 
C-reactive protein biomarkers on stress and alexithymia 
in individuals, who are diagnosed with chronic renal 
failure and receive hemodialysis treatment.
Methods The research environment was formed of 
patients who underwent hemodialysis treatment in a 
hospital in Turkey. The subject group was comprised 
of 72 individuals. Demographic data form, biomarker 
list form, Hemodialysis Stressor Scale and Toronto 
Alexithymia Scale were used in the research.
Results It was found that the levels of perceived stress 
of individuals who participated in the research were 
high at all dimensions, and 59.7% were alexithymic. 
The means of the total scale scores of all patients were 
calculated as 87.81 ± 13.59 for Hemodialysis Stressor 
Scale and 62.46 ± 9.84 for Toronto Alexithymia Scale. 
The relationship between the Toronto Alexithymia Scale 
and Hemodialysis Stressor Scale and selected biomark-
ers were determined (P < 0.05).
Conclusion It was concluded that stress and alex-
ithymic feelings were high in patients who received 
hemodialysis treatment, and that there is a relationship 
between C-reactive protein, creatinine, sodium, hemo-
globin, hematocrit, potassium from the biomarkers and 
the scales and scale sub-dimensions. It is necessary to 
increase the awareness of nurses on the importance of 
the skills to communicate with individuals who have to 
cope with stress, manage emotions, and have high stress 
and emotional deprivation.
Key words alexithymia; biomarkers; chronic renal 
failure; hemodialysis; stress
While chronic renal failure (CRF) causes many 
physical problems in patients, sick individuals are also 
psychologically and socially influenced by hemodialysis 
treatment and the feeling of being dependent on a 
mechanical instrument brought about by the treatment. 
CRF patients under hemodialysis treatment constitute 
a specific group due to changes not only in their health 
but also in other social environments.1, 2 Hemodialysis 
treatment gives rise to basic fluid electrolyte imbal-
ances.3 The stress levels in such patients rise due to 
physical and psychological problems that emerge during 
the uremic period, sudden changes in biomarkers, 
medication treatment, diet treatment and hemodialysis 
treatment.2, 4 And when the increased stress becomes 
continuous, it sets the ground for alexithymia in direct 
proportion to the disease.5
Alexithymia is defined as restriction in imagina-
tion and lack of ability to fantasize, inadequacy in 
distinguishing between emotions, thoughts and physi-
ological reactions, and problems in recognizing and 
expressing emotions.6 Alexithymic behavior patterns 
observed in patients have been defined as: nervousness, 
short temperedness, touchiness, introversion, loss of 
interest and desire, loss of hope for the future, distress, 
anxiety and emotional deprivation as a result of these.5, 7 
Feelings such as fear, anger, and sorrow in alexithymic 
individuals create a loss in persuasive properties and 
may cause individuals to mask their emotions in some 
way.8 It has been observed that alexithymia studies in 
the literature are primarily concentrated on psychiatric 
diseases.9 As a result of our research, we found out that 
alexithymia can be observed in individuals who have 
chronic diseases, even if they have not been identified in 
conducted research.10, 11 Senturk et al. (2000) reported 
that CRF patients who received hemodialysis treatment 
had an intermediate level of depression, while more 
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than half of them were alexithymic.5 In their research, 
Pop-Jordanova and Polenakovic (2014) determined that 
half of the patients who received hemodialysis treatment 
were alexithymic, irrespective of sex, and the com-
parison they made with healthy individuals and cancer 
patients emphasized that alexithymia was higher in pa-
tients who received hemodialysis treatment as compared 
to the other groups.12 In their research, Kojima et al. 
(2007) concluded that hemodialysis patients were prone 
to depression and were alexithymic.13
Nursing care includes the planning and implemen-
tation of appropriate attempts aimed at relieving stress 
in the patient, the quality of life from a biological, psy-
chosocial and socio-cultural perspective, and realizing 
the ability of the individual to cope with stress factors or 
the problems that develop as a result of the stressors.14 
It is not appropriate to handle symptom management 
or the psychosocial dimension of CRF solely through 
a nursing approach.15 Therefore, a nurse has to adopt a 
holistic approach while performing care activities dur-
ing CRF and hemodialysis treatment.
In this research, which was not initially designed 
as experimental, we planned to obtain evidence that 
physical findings obtained from tangible data may be 
related to alexithymia as a psychological phenomenon. 
As the main idea underlying the research design, we 
thought that biomarkers that changed biochemically in 
the blood and serum in chronic kidney failure could be 
recorded as tangible data and the physical changes that 
occurred in the body could be related to alexithymia as 
stress on a structured scale. Thus, the alexithymia and 
stress table of hemodialysis patients could be discovered 
in proportion to the pre-treatment and post-treatment 
changes in their biomarkers. We believe that our study 
could assist nurses who work as care providers for CRF 
patients receiving hemodialysis treatment by providing 
holistic care through evaluating the relationship of the 
biomarkers with the stress levels and alexithymia of the 
patients, and developing a guide aimed toward helping 
such patients. Accordingly, the research was conducted 
in order to evaluate the relationship between the se-
lected biomarkers of patients who receive hemodialysis 
treatment with stress and alexithymia.
MATERIALS AND METHODS
The prospective cross-sectional demographic data of our 
study was designed to assess the relationship between 
biomarkers, hemodialysis stressors and alexithymia. 
Our study was conducted in a hospital hemodialysis 
unit in Turkey, and data was collected. The sample was 
comprised of 72 hemodialysis patients.
The inclusion criteria were:
• taking hemodialysis treatment for six months or 
more due to CRF diagnosis
• being eighteen years of age or older
• being literate in Turkish, reading the informed con-
sent form and agreeing to participate in the work;
The exclusion criteria were:
• having a psychiatric diagnosis, tumor and/or 
metastasis
• taking hemodialysis treatment without a diagnosis 
of CRF
• undergoing hemodialysis treatment with a diagnosis 
of CRF for less than 6 months.
Patients’ demographic characteristics: the data 
collection form as prepared by the researcher in relation 
to the hemodialysis treatment to determine the patients’ 
demographic data was used in this research. This 
form included 11 questions, including patients’ socio-
demographic data, how many medications they took, 
hemodialysis acquisition time, age, gender, additional 
chronic disease status, education status, marital status, 
income level, occupation and working status.
On the biomarker list, the values of the following 
were noted for collection: urea, creatinine, hemogram, 
hematocrit, albumin, sodium, potassium, C reactive 
protein (CRP).
Hemod ia lys i s s t r e s sor s ca le ( HSS ): t he 
Hemodialysis Stressor Scale was used to determine 
stress. The scale was developed by Baldree et al. and 
was adapted for Turkish patients by Kara.14 The HSS is 
a five-point Likert-type scale and is coded as “always” 5, 
“often” 4, “sometimes” 3, “rarely” 2 and “never” 1. HSS 
has been identified in hemodialysis patients as physical 
(HSS-1) and psychosocial (HSS-2).16 The physical he-
modialysis stressor score is 6–30 and the psychosocial 
hemodialysis stressor score is 23–115 points. The total 
score of HSS varies between 29–145 points. The total 
HSS score ranges from 29–145 and an increased score 
on the scale indicates that the perceived stress level is 
higher.16
The Toronto Alexithymia Scale (TAS-20): the 
Toronto Alexithymia Scale was used to measure alexi-
thymia. The self-reporting scale consists of 20 items 
evaluating alexithymia, with a score of 1–5, likert-type 
and three subscales: “difficulty identifying feelings” 
(TAS-1), “difficulty expressing emotions” (TAS-2) and 
“outward-thinking” (TAS-3). Individuals are asked to 
mark the most appropriate score for each item from 
“never”, “rarely”, “sometimes”, “often” and “always”. 
This scale was developed by Bagby et al. (1994) and 
Turkish adaptation was done by Gulec et al. (2009). 
Items 4, 5, 10, 18 and 19 on the scale are scored in 
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reverse17; the cut-off value of TAS-20 is 51 or less with 
52–60 indicating possible alexithymia and a score of > 
61 indicating alexithymia.18
Data collection and procedure
This research was carried out between 03.08.2016 and 
04.04.2017. The single measurement biomarker values 
of the participants in the study’s planning stage were 
examined. The biomarker values were measured im-
mediately before taking hemodialysis treatment and 
evaluations were done as follows: information was 
given verbally prior to application, then confirmed by 
filling in informed consent forms, and finally approved 
on the basis of volunteerism. The questionnaires were 
performed as face-to-face interviews by the researcher 
and coded with patients’ initials and protocol numbers 
in order to prevent repetition of information.
Analysis
The distribution of continuous variables such as age, 
albumin, and CRP in the study were examined by the 
Shapiro–Wilk test and normality graphs. All continu-
ous measurements were expressed as mean ± standard 
deviation (mean ± s), the number of drugs used daily 
was median (min-max), and categorical variables were 
expressed as number (n) and percentage (%). The con-
sistency of responses to HSS and TAS-20 was assessed 
with Cronbach’s α. Subgroups of HSS, TAS-20, and 
scales were tested by the Mann–Whitney U test and 
independent sample tests (t test and χ2 test) according 
to gender and additional chronic illness status, the 
Kruskal–Wallis test, and one-way ANOVA according 
to marital status and hemodialysis time. Relationships 
between scale scores, biomarkers, and the number 
of drugs used daily were examined by Pearson or 
Spearman Correlation analyses depending on the distri-
bution of variables. Statistical significance level was P < 
0.05. Cronbach’s α value for HSS in our study was 0.789 
and for TAS-20, 0.737. Accordingly, the consistency of 
responses to the scale was acceptable (0.70 < α < 0.80).
Limitations
Only a single center was studied, the number of ses-
sions was not examined as a variable, and only a single 
measurement was used before hemodialysis. These 
conditions were determined as limitations of the study.
RESULTS
The following findings were obtained in the data 
obtained from our study. When the alexithymia levels 
of subjects participating in the study were examined, it 
was found that 59.7% (n = 43) were alexithymic (Table 
1).
Among the individuals included in our study, 
55.6% (n = 40) were men, 66.7% (n = 48) were married, 
and 63.9% (n = 46) had additional chronic diseases. 
Hemodialysis durations were 30.6% (n = 22) for six 
months to two years, 27.7% (n = 20) for 2–5 years, 
15.3% (n = 10) for 5–8 years, 8.3% (n = 6) for 8–10 
years, and 18.1% (n = 13) for > 10 years (Table 2). The 
relationship between the subscales of demographic data, 
HSS, HSS subscales, TAS-20, and TAS-20 subscales 
are shown in Table 2. Additional chronic disease and 
the HSS-1 subscale were statistically significant.
The biomarkers of urea, creatinine, hemoglobin, 
hematocrit, albumin, sodium, potassium, calcium, 
phosphorus, and C-reactive protein (CRP) values of the 
subjects who participate in the study were evaluated. 
The median number of medications used by the patients 
on a daily basis was three (min–max: 1–20). Normally 
deviating values were determined and the relationship 
between the HSS, HSS subscales, TAS-20, and TAS-20 
subscale scores was assessed. A positive correlation was 
found between the TAS-20 point average and the HSS-1, 
between the HSS score average and TAS-1, between 
CRP and HSS, HSS-2 and the number of drugs used 
daily and HSS-1 in the direction of the obtained results. 
There was a negative correlation between creatinine and 
HSS-1, TAS-20, TAS-2, TAS-3, between hemoglobin 
and TAS-1, between hematocrit and TAS-1, between 
sodium and HSS-1, between potassium and TAS-3 (Table 
3).
DISCUSSION
Emotional disorders, time, diet and functional restric-
tions, self-change and fear of death are quite high 
for individuals who are under chronic hemodialysis 
treatment in addition to the exhaustion originating from 
Table 1. Percentage distributions according to alexithymia levels of hemodialysis patients (n = 72)
Sample (n) Percent (%)
No alexithymia (51 points and below) 10 13.9
Possible alexithymia (52–60 points) 19 26.4
Alexithymia (61 points and above) 43 59.7
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the disease. Many problems that exist in this patient 
group were found to be factors in the development 
of alexithymia. Both the literature and the results of 
our study suggest that alexithymia is observed at high 
levels in chronic diseases (Table 1). Pop-Jordanova 
and Polenakovic reported that half of the patients who 
received hemodialysis treatment in Macedonia (n = 
230) appeared alexithymic.12 In a study they conducted, 
Sinatra et al. (2011) found that the primary psychiatric 
outlook that accompanied depression was alexithymia 
in patients under hemodialysis treatment for 4 years 
and above.19 As a result of our research, we found that 
the increase in the length of hemodialysis treatment is 
in direct proportion to the emergence of alexithymic 
symptoms.
It was reported that 31.5% of the subjects received 
hemodialysis treatment for nine months or less, 32.5% 
received treatment between 9 and 24 months, and 36% 
were under hemodialysis treatment for more than 24 
months in research conducted by Davison and Jhangri 
(2005), while the mean hemodialysis treatment period 
of hemodialysis patients was reported as 58.75 ± 48.94 
months in a different study.20, 21 In our research, we 
determined that 22 patients (30.6%) had begun hemo-
dialysis for 6 months-2 years, 20 patients (27.7%) for 
2–5 years, 11 patients (15.3%) for 5–8 years, 6 patients 
(8.3%) for 8–10 years and 13 patients (18.1%) for more 
than 10 years (Table 2). The exposure of hemodialysis 
patients to physical and psychological changes that they 
have to cope with increases in direct proportion to the 
increase in their treatment periods. This process based 
on a patient’s experience with hemodialysis should be 
carefully followed up also with respect to the patient 
and healthcare employees.
Physiological changes such as edema and ultrafiltra-
tion during hemodialysis treatment may render the bio-
markers of individuals unstable. In a study conducted by 
Griva et al., it was found that the hemoglobin value was 
low in hemodialysis treatment.22 In a systematic compi-
lation, statistical significance was reported with respect 
to living quality in health and the 3 sub-dimensions that 
examined CRP value in hemodialysis patients.23 In a 
study where Kalender et al. evaluated the biomarkers 
with respect to receiving hemodialysis treatment for 2 
or 3 sessions per week, they found that the hemoglobin, 
hematocrit, albumin and calcium values were higher 
in individuals who received hemodialysis treatment in 
3 sessions per week, while urea, creatinine, potassium 
and phosphorus values where higher in individuals who 
received hemodialysis treatment in 2 sessions per week. 
In conclusion, they found that the treatment adequacy of 
individuals who received hemodialysis treatment for 3 
sessions per week was higher as compared to those who 
received 2 sessions per week.24 When we examined 
studies evaluating hemodialysis patients, we observed 
that biomarkers have multi-dimensional influences on 
the health of patients. We believed that these parameters 
increased the hemodialysis origin stress of patients and 
Table 2. Demographic data rates of individuals who received hemodialysis treatment, evaluation of demograph-
ic data with HSS, HSS subscales, TAS-20, TAS-20 subscales
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set the background for alexithymic to arise.
When we evaluated the variables with HSS and 
HSS sub-dimensions in our study, we concluded that 
there was no relationship between the sex, marital sta-
tus, hemodialysis period, accompanying chronic disease 
variables and the mean scores of the scale and scale 
sub-dimensions (P > 0.05). The relationship between 
the presence of accompanying chronic disease and HSS 
physical sub-dimension mean scores was found to be 
statistically significant (t = 3.394, P = 0.001). In their 
study, Shahrokhi et al. (2014) reported that there was 
no statistically significant relationship between the type 
of hemodialysis dependent stressor, and sex, marital 
status, educational status, number of weekly hemodialy-
sis sessions and hemodialysis period.25 Mok and Tam 
(2001) reported similar conclusions in their findings.26 
In a similar study, Ahmad and Nazly (2015) reported 
that there is a negative relationship between coping with 
stress and seeking social support as the hemodialysis 
period increases. When they examined individuals 
receiving hemodialysis treatment as based on the sex 
variable in the same study, they reported that there is 
a positive relationship between HSS, HSS physical 
and psychosocial sub-dimensions and the differences 
between them was statistically significant.27 Most of 
the physical stressors include fatigue, fluid restriction, 
nutrition limitations, and difficulty with dressing due to 
arterial and venous catheterization. Meanwhile, most 
of the psychosocial stressors may be considered as loss 
of time, problems with disorientation, transportation, 
sleeping disorders, dependence and boredom. At the 
same time, we may also include changes of roles in the 
family with respect to children, isolation and transfer 
problems. It was concluded that these variables are 
influential on hemodialysis origin stress.
We compared the scores of the patients from the 
Toronto Alexithymia Scale and sub-dimensions with 
sex, marital status, accompanying chronic disease status 
Table 3. Assessment of the relationship between biomarkers, total score average of TAS-20, total mean score of 
HSS and the number of daily medicines used by HSS, HSS subscales, TAS-20, TAS-20 subscales
Biomarkers x̄ ± SD HSS HSS-1 HSS-2 TAS-20 TAS-1 TAS-2 TAS-3
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and periods of entering hemodialysis (Table 2). We 
determined the TAS-20 mean scores of female patients 
as 62.19 ± 9.49, and that of the male patients as 62.67 ± 
10.22. We determined a similarity in TAS-20 scores as 
based on sex (t = 0.208, P = 0.836). When we examined 
the scores of the TAS-20 sub-dimensions with respect 
to sex, we determined that the mean scores were similar 
and concluded that sex is not related to alexithymia (P > 
0.05). The TAS-20 mean scores and the mean scores of 
the sub-dimensions were not statistically significant as 
based on marital status (P > 0.05). Pistorio et al. (2017) 
found that patients who were in the process of kidney 
transplantation and had physical and somatic complaints 
exhibited a more alexithymic appearance and the 
difference between them was statistically significant. 
In the same study, they reported that there was no 
relationship when examined based on the sex variable.10 
In a study that Pop-Jordanova et al. conducted (2014), 
they reported that there is a linear relationship between 
age and alexithymia. At the same time, they found that 
alexithymic appearance was relatively higher in males 
when evaluated based on sex. When they examined 
with factor analysis based on TAS-20 sub-dimensions, 
they found that TAS-1 and TAS-2 age and hemodialysis 
entry periods were not significant, while the TAS-3 
extroverted thinking sub-dimension was significant.12 
As reported in a study conducted in Japan, individuals 
under end-stage renal failure were divided into two 
groups based on depression scores and their alexithymic 
appearances were examined. It was reported that the 
alexithymic appearance was higher in individuals who 
had high depression scores. In this study, they reported 
that there is a negative relationship between period of 
beginning hemodialysis and alexithymic appearance.13 
End-stage renal failure and the physical stress created 
by the fluid changes during hemodialysis treatment lead 
to psychosomatic complaints and this condition nega-
tively influences appearance as the treatment period 
increases. Furthermore, accompanying chronic diseases 
and other psychiatric appearances, and the inability of 
the individual to distinguish between feelings that are 
expressed as emotional obtuseness increase alexithymia. 
The individual who appears alexithymic experiences 
difficulty in managing the treatment processes, and this 
may at the same time cause his physical condition to get 
worse.
Correlation analysis was made between the scores 
that hemodialysis patients received from the HSS and 
HSS physical, psychosocial sub-dimensions and the bio-
chemistry results and the number of daily medications 
used (Table 3). In one study (Harwood et al. 2009), the 
biomarkers of CRF patients were found to be associated 
directly with their stress and coping strategies and found 
them to be statistically significant. While hemoglobin 
and albumin from these parameters were statistically 
significant, it was reported that urea and creatinine 
parameters were not influential on stress.28 Accordingly, 
the biomarker change of individuals may make it dif-
ficult to cope with stress since it influences their fatigue 
levels. The pre-session biomarker data on hemodialysis 
patients may provide information also on psychosocial 
variables, in addition to the individual’s potential physi-
cal condition. Nurses should also have knowledge on 
various blood parameters similar to the dialysis process. 
Such evaluation will increase the patient’s quality 
of care by the nurse and positively influence patient 
comfort.
Correlation analysis made between the scores that 
hemodialysis patients received from the TAS-20 and 
sub-dimensions and the biochemistry results, and the 
number of daily medications used and the relationship 
between them were evaluated (Table 3). Lai et al. (2017) 
examined the biological indicators and alexithymic 
appearance in renal failure patients who were grouped 
based on treatment modalities, and demonstrated that 
phosphorus and hemoglobin levels directly influenced 
psychological condition and there was an inversely pro-
portional relationship. In the same study, they evaluated 
potassium, calcium, phosphorus and hemoglobin from 
the biomarker data of the patients and their emotional 
levels, and found them to be statistically significant.29 
Calia et al. (2015) evaluated the emotional status of 
patients and alexithymia in their study. They compared 
the physical parameters they examined with creatinine 
and blood urea nitrogen levels. There was a statistical 
significance between alexithymia appearance and 
physiological parameters. Meanwhile, according to a 
self-evaluation scale related to negative emotion control, 
they only found a negative relationship between creati-
nine and negative emotion control.30
There may be changes in the patient’s metabolic 
activities, blood circulation, physiological variables 
and psychological condition in renal failure. The fluid 
change in the body leads to stress and fatigue in order 
to adapt to the sudden changes in the biomarkers, ir-
respective of the CRF treatment that is used. Emotional 
status changes. Therefore, it is important for the nurse 
to periodically evaluate the records of this group of 
patients, who are followed up in the clinic and at home, 
including their biomarkers, and incorporate this into the 
care plans. At the same time, reducing stress, increasing 
harmony, planning the treatment and diet regime and 
increasing comfort are important indicators in reflecting 
the quality of nursing care.
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In conclusion, while urea, creatinine, phosphorus, 
CRP values were found to be high, hemoglobin, sodium, 
albumin and calcium values were found to be low from 
the selected biomarkers in individuals receiving hemo-
dialysis treatment. The stress levels of the patients were 
high and it was determined that more than half of the 
patients had alexithymia. It was determined that there 
was a relationship between the variables on accompany-
ing chronic disease and HSS physical sub-dimensions. 
A relationship was determined between HSS and CRP, 
between HSS physical sub-dimensions and TAS-20, 
creatinine, sodium and the number of medications used 
daily, and between the HSS psychosocial sub-dimension 
and CRP. We conclude that there was a relationship be-
tween TAS-20 and creatinine, between TAS-1 and HSS, 
hemoglobin, hematocrit, between TAS-2 and creatinine 
and between TAS-3 and creatinine and potassium in 
individuals who undergo hemodialysis. In line with our 
conclusions, we found evidence of the potential influ-
ence of physical health on mental health. A repeated 
study may be planned with multiple measurements in 
order to determine the fluctuations and what their influ-
ences on patients are. In our study, we evaluated the 
medication quantities and not the active ingredients or 
the generic names of the medications. The evidence we 
expected to arrive at while designing our research was 
determined as a result of the study data.
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